Avian Pathology Journal Impact Factor & Information

Publisher: Taylor & Francis

Journal description

Avian Pathology is a leading journal that has the aim of disseminating knowledge concerned with the entire field of research on infectious and non-infectious diseases of poultry and all other birds. Original research is published in the form of full papers, short communications and case reports. Subject areas include pathology, immune responses, vaccines, genetics e.g. in relation to disease resistance/susceptibility, epidemiology, diagnosis, detection and characterization of pathogens, gene sequences, and physiology and biochemistry (provided that the physiological and biochemical data refer to disease). Authoritative Reviews, Commentary Articles on topical subjects and Technical Reviews (detection and differentiation of pathogens) are published from time to time.

Current impact factor: 2.04

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 2.041
2012 Impact Factor 1.729
2011 Impact Factor 1.711
2010 Impact Factor 1.967
2009 Impact Factor 1.654
2008 Impact Factor 1.7
2007 Impact Factor 1.257
2006 Impact Factor 1.809
2005 Impact Factor 1.789
2004 Impact Factor 1.387
2003 Impact Factor 1.271
2002 Impact Factor 1.514
2001 Impact Factor 1.655
2000 Impact Factor 1.428
1999 Impact Factor 0.845
1998 Impact Factor 0.705
1997 Impact Factor 0.769
1996 Impact Factor 0.754
1995 Impact Factor 0.734
1994 Impact Factor 0.629
1993 Impact Factor 0.664
1992 Impact Factor 1.089

Impact factor over time

Impact factor
Year

Additional details

5-year impact 1.95
Cited half-life 9.60
Immediacy index 0.30
Eigenfactor 0.00
Article influence 0.55
Website Avian Pathology website
Other titles Avian pathology (En ligne)
ISSN 1465-3338
OCLC 57214916
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Taylor & Francis

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Some individual journals may have policies prohibiting pre-print archiving
    • On author's personal website or departmental website immediately
    • On institutional repository or subject-based repository after either 12 months embargo
    • Publisher's version/PDF cannot be used
    • On a non-profit server
    • Published source must be acknowledged
    • Must link to publisher version
    • Set statements to accompany deposits (see policy)
    • The publisher will deposit in on behalf of authors to a designated institutional repository including PubMed Central, where a deposit agreement exists with the repository
    • STM: Science, Technology and Medicine
    • Publisher last contacted on 25/03/2014
    • This policy is an exception to the default policies of 'Taylor & Francis'
  • Classification
    ​ green

Publications in this journal

  • Avian Pathology 12/2015;
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the present study, the immune protective effects of recombinant microneme protein 7 of Eimeria maxima (rEmMIC7) and a DNA vaccine encoding this antigen (pVAX1-EmMIC7) on experimental challenge were evaluated. Two-week-old chickens were randomly divided into five groups. Experimental group of chickens were immunized with 100 μg DNA vaccine pVAX1-MIC7 or 200 μg rEmMIC7, while control groups of chickens were injected with pVAX1 plasmid or sterile PBS. The results showed that the anti-EmMIC7 antibody titers in chickens of both rEmMIC7 and pVAX1-MIC7 groups were significantly higher as compared to PBS and pVAX1 control (P < 0.05). The splenocytes from both vaccinated groups of chickens displayed significantly greater proliferation response compared with the controls (P < 0.05). Serum from chickens immunized with pVAX1-MIC7 and rEmMIC7 displayed significantly high levels of IL-2, IFN-γ, IL-10, IL-17, TGF-β and IL-4 (P < 0.05) compared to those of negative controls. The challenge experiment results showed that both the recombinant antigen and the DNA vaccine could obviously alleviate jejunum lesions, body weight loss and enhance oocyst decrease ratio. The anti-coccidial index (ACI) of the pVAX1-MIC7 group was 167.84, higher than that of the recombinant MIC7 protein group, 167.10. Our data suggested that immunization with EmMIC7 was effective in imparting partial protection against E. maxima challenge in chickens and it could be an effective antigen candidate for the development of new vaccines against E. maxima.
    Avian Pathology 07/2015; DOI:10.1080/03079457.2015.1071780
  • [Show abstract] [Hide abstract]
    ABSTRACT: Genotyping of 7 IBV strains isolated in Brazil showed that all belonged to the common Brazilian genotype and that these strains were closest to the subcluster of strain IBV/Brazil/2007/USP-19. Pathotyping of four selected Brazilian strains showed that they all caused a considerable level of ciliostasis in the trachea but at a somewhat lower level than did M41 and Brazilian strains 50/96, 57/96, 62/96 and 64/96 representing 4 different serotypes that had been reported earlier. In contrast to the M41 challenge strain, all Brazilian isolates replicated in kidney tissue in a high percentage of non-vaccinated challenged birds, clearly showing that they are nephropathogenic. As for the tracheal protection, the results using Massachusetts (Mass) vaccination against the recent strains seemed to show protection higher on average than for the strains reported earlier. A single or twofold vaccination with a Mass vaccine resulted in a mean tracheal protection level against the 4 challenge strains of 92% and 90% respectively, whereas a single and twofold vaccination with a Mass vaccine halved the percentage of infected kidneys (14% and 13%, respectively, P < 0.05) compared to that of the unvaccinated birds (27%). The combination of the Mass and the 793B vaccine provided on average a tracheal protection of 99% and a reduction of the percentage of infected kidneys to a mean of 2%. This was a significantly (P < 0.05) higher protection than was achieved by a single or twofold Mass vaccination, showing the added value of the 793B vaccination following priming with a vaccine of the Mass type.
    Avian Pathology 07/2015; DOI:10.1080/03079457.2015.1058916
  • [Show abstract] [Hide abstract]
    ABSTRACT: The incidence and economic impact of the Escherichia coli peritonitis syndrome (EPS) characterized by acute mortality, were estimated in chicken eggs producing farms in the Netherlands in 2013. The incidence was significantly higher (P < 0.05) in the meat-sector (35% affected farms) compared to the layer-sector (7% affected farms). In consumption eggs producing farms EPS occurred on 12% of the free range and organic farms, while it was found on 1% and 4% of the cage and barn farms, respectively. Data from four layer and two broiler breeder flocks with EPS were used to estimate the overall economic impact of the disease. Mean numbers of eggs lost were 10 and 11 per hen housed (phh), while mean slaughter weight loss was 0.2 kg and 0.5 kg phh in the four layer and two broiler breeder flocks, respectively. Total losses including costs of destruction of dead hens, compensated for reduced feed intake due to a smaller flock size, ranged from € 0.28 phh (cage farms) to € 9.75 phh (grandparent farms) in the layer-sector and from € 1.87 phh (parent farms) to € 10.73 phh (grandparent farms) in the meat-sector. Antibiotics against EPS were given often and repeatedly especially in the meat-sector. Including the costs of antibiotics, total losses were estimated at € 0.4 million, € 3.3 million and € 3.7 million for the layer-sector, the meat-sector and poultry farming as a whole, respectively. Research focusing on the prevention and treatment of EPS is justified by its severe clinical and economic impact.
    Avian Pathology 06/2015; DOI:10.1080/03079457.2015.1060584
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ornithobacterium rhinotracheale (ORT) is a Gram-negative bacillus that causes respiratory disease in birds, affecting directly the poultry industry. The mechanisms behind these infections are not completely known. Currently, its capacity to form biofilms on inert surfaces has been reported; however, the conditions for biofilm development have not been described yet. The present work was aimed at identifying the conditions that enhance in vitro biofilm formation and development by ORT. For this, serovars A-E were analyzed to assess their ability to induce biofilm development on 96-well flat-bottom polystyrene microtiter plates under diverse conditions: temperature, incubation time, and CO2 concentration. The results obtained showed not only that all serovars have the ability to produce in vitro biofilms, but also that the optimal conditions for biofilm density were 40°C after 72 hours at an elevated CO2 concentration. In conclusion, ORT biofilm formation depends on the environmental conditions and may contribute to the persistence of this microorganism.
    Avian Pathology 06/2015; DOI:10.1080/03079457.2015.1059923
  • Avian Pathology 06/2015; 44(3):237-8. DOI:10.1080/03079457.2015.1029765
  • [Show abstract] [Hide abstract]
    ABSTRACT: Two 1-year old Roulroul partridges (Rollulus rouloul), one male and one female, were presented because of eye problems and anorexia. Already 20 of the 30 Roulroul partridges in the owner's collection had died. The affected animals stopped eating, became thinner, and eventually died. Antibiotic treatment, which started because of the suspicion of a septicemic process, was unsuccessful. At clinical examination of the two partridges it was found that in both birds, one eye ball was filled with a whitish yellow amorphous material and the other eye ball of the female showed a distinct corneal opacity. Both presented animals were euthanized. Necropsy revealed no significant abnormalities in addition to the eye lesions. Histology and immunohistochemistry of the female's eye revealed an infiltrate of T-lymphocytes corresponding to ocular lymphoma. Herpesvirus genus-specific PCR, followed by Sanger sequencing confirmed the presumptive diagnosis of Marek's disease in both animals. To our knowledge, this is the first confirmed a case of infection with Gallid Herpesvirus 2 (Marek's disease virus) in partridges and the first case in this specific species.
    Avian Pathology 05/2015; DOI:10.1080/03079457.2015.1056088
  • [Show abstract] [Hide abstract]
    ABSTRACT: Taishan Pinus massoniana pollen polysaccharide (TPPPS), propolis (PP), and aloe polysaccharide (AP), used as adjuvants, have been proven to possess immunity-enhancing functions. However, we are largely unknown their collaborative immunomodulatory effects. To determine which combination can induce the best effects, the three adjuvants were separately or conjointly added into the Bordetella avium (B. avium) inactivated vaccines to investigate their co-adjuvant effects on the vaccinated chickens. We found that, among all six adjuvant-treated vaccine inoculated groups (TPPPS, PP, AP, TPPPS-PP, PP-AP, and TPPPS-AP), the chickens inoculated with TPPPS, PP, or TPPPS-PP adjuvant vaccines showed significantly higher levels of antibody titer, cytokine, lymphocyte transformation, and peripheral blood T-lymphocyte count than those of non-adjuvant vaccine inoculated groups (P < 0.05), indicating the good immune-enhanced effects of TPPPS and PP. Among which, the TPPPS-PP group showed the highest levels of antibody titers and interleukin-2 (IL-2) at 14-28 days post the first inoculation (dpi), lymphocyte transformation rates (LTRs) at 14-35 dpi, CD4(+) T-lymphocyte counts at 14-42 dpi, and CD8(+) T-lymphocyte counts at 28 dpi. The results revealed that B. avium inactivated vaccine used conjointly with TPPPS and PP induced the strongest humoral and cellular immune responses. Thus, there was a synergistic effect between TPPPS and PP on enhancing immunity, which implied that they can be used as a novel adjuvant formulation for the development of poultry vaccines.
    Avian Pathology 05/2015; DOI:10.1080/03079457.2015.1040372
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 1-year old male Himalayan monal (Lophophorus impejanus) was presented for veterinary attention with a history of chronic wasting, weakness, and ataxia. The bird died, and post mortem findings included mild non-suppurative encephalitis and degenerative encephalopathy, lymphoplasmacytic myenteric ganglioneuritis (particularly of the proventriculus), and Wallerian degeneration of the sciatic nerves. Avian bornavirus (ABV) was identified in the brain by immunohistochemistry and reverse-transcriptase polymerase chain reaction (RT-PCR). Sequencing of the RT-PCR product indicated the presence of ABV genotype 4, which is generally associated with disease in psittacine birds. Subsequent to the death of the pheasant, ABV genotype 4 was identified at autopsy from a juvenile white-bellied caique (Pionites leucogaster) in the same collection. We hypothesize that the pheasant became infected through contact with psittacine birds with which it shared an aviary. We believe this to be the first reported case of natural ABV infection in a bird in the Order Galliformes.
    Avian Pathology 05/2015; DOI:10.1080/03079457.2015.1050956
  • [Show abstract] [Hide abstract]
    ABSTRACT: Neospora caninum is an intracellular protozoan parasite with a wide range of intermediate animal hosts. There is little information describing the prevalence and genetic characterization of N. caninum in bird hosts worldwide and in Iran. In this study, a total 217 brain samples of house sparrow (Passer domesticus) were examined for N. caninum presence by nested-PCR targeting the Nc-5 gene. Neospora caninum DNA was detected in 3.68% (8/217) of sparrows. Sequencing of the Nc5 genomic DNA revealed 97-99% of similarity with N. caninum sequences deposited in Genbank. To our knowledge, this study is the first molecular evidence of N. caninum DNA in bird hosts in Iran. The results of this study highlight the role of the house sparrow (Passer domesticus) in maintaining and spreading N. caninum infection to canines in the feral and domestic environment.
    Avian Pathology 05/2015; DOI:10.1080/03079457.2015.1050583
  • [Show abstract] [Hide abstract]
    ABSTRACT: Marek's disease virus (MDV) is an oncogenic alphaherpesvirus and the causative agent of Marek's disease (MD), characterized by immunosuppression, paralysis, nerve enlargement, and induction of T-cell lymphomas in chickens. Despite widespread usage of vaccines since the 1970's to control MD, more virulent field strains of MDV have emerged that overcome vaccinal protection, necessitating the development of new and more protective MD vaccines. The ∆Meq virus, a recombinant Md5 strain MDV lacking the viral oncogene Meq, is one candidate MD vaccine with great potential but unfortunately it also causes bursal-thymic atrophy (BTA) in maternal antibody negative chickens, raising concerns that impede commercial use as a vaccine. Previously, we identified a point mutation within UL5 that reduced in vivo replication in attenuated viruses. We proposed that introduction of the UL5 point mutation into the ∆Meq virus would reduce in vivo replication and eliminate BTA yet potentially retain high protective abilities. In birds, the ∆Meq+UL5 recombinant MDV had reduced replication compared to the original ∆Meq virus, while weights of lymphoid organs indicated that ∆Meq+UL5 did not induce BTA, supporting the hypothesis that reduction of in vivo replication would also abolish BTA. Vaccine trials of the ∆Meq+UL5 virus compared to other ∆Meq-based viruses and commercial vaccines show that, while the ∆Meq+UL5 does provide vaccinal protection, this protection was also reduced compared to the original ∆Meq virus. Therefore, it appears that a very delicate balance is required between levels of replication able to induce high vaccinal protection, yet not so high as to induce BTA.
    Avian Pathology 05/2015; DOI:10.1080/03079457.2015.1041366
  • [Show abstract] [Hide abstract]
    ABSTRACT: The study was conducted to investigate the role of aflatoxin on the infectivity and transmissibility of H9N2 AI virus. The experiment was performed on 80 non-vaccinated turkeys, divided into four groups of 20 birds each. Group A was kept as non-infected and a non-treated negative control; group B was inoculated intratracheally with H9N2 AI virus (1 × 10(7) EID50) at 4 week of age; group C was fed on a diet containing 0.5 ppm aflatoxin from day one through the entire experiment period and group D was fed on diet containing 0.5 ppm aflatoxin like Group C but inoculated intratracheally with H9N2 AI virus (1 × 10(7) EID50) at the 4(th) week of age and then mixed with naïve birds. Infected and contact birds showed clinical signs of different severity, showing the most prominent disease signs in birds of the aflatoxin+H9N2 group. All infected birds showed virus shedding, however, the pattern of virus shedding was different for birds of the aflatoxin+H9N2 group showing pronounced virus secretion. Similarly, efficient transmission of virus was observed between infected and contact birds, but more prominent virus transmission was seen in those birds inoculated and fed aflatoxin-treated diet. Moreover, significant lower antibody titres against H9N2 AIV were observed in birds fed aflatoxin-treated diet, indicating an immunotoxic nature of aflatoxin as the reason for poor seroconversion. Similarly, decreased IFNγ mRNA expression and higher mortality (35%) suggest an immunotoxic and immunosuppressive effect of aflatoxin leading to enhanced pathogenesis of H9N2 viruses in aflatoxin-fed birds. The immunosuppressive nature of aflatoxin might delay influenza virus clearance and this may be one of the reasons for increased pathogenicity of H9N2 LPAI viruses in turkeys under field conditions.
    Avian Pathology 05/2015; DOI:10.1080/03079457.2015.1046813
  • [Show abstract] [Hide abstract]
    ABSTRACT: Live Mycoplasma gallisepticum vaccines are used for the control of respiratory disease, egg production losses and egg transmission associated with M. gallisepticum infection in long-lived poultry. The first field case of apparent increased virulence and vertical transmission of ts-11, a live M. gallisepticum vaccine, has been reported. In that study a M. gallisepticum isolate from the broiler progeny of ts-11-vaccinated breeders was genotyped as ts-11 by sequence analysis of four different genes and Randomly Amplified Polymorphic DNA, and found to be significantly more virulent than ts-11 vaccine. The objective of the current study was to evaluate the rate of egg transmission and pathogenicity of ts-11 vaccine and isolates recovered from ts-11-vaccinated breeders (K6222B) and their broiler progeny (K6216D) which had been genotyped as ts-11. Groups of 28-week-old specific pathogen free chickens at 87% average weekly egg production were inoculated with sterile broth media (negative controls), ts-11 vaccine, K6222B, K6216D or R strain (positive controls) by eye-drop and aerosol. K6216D transmitted via the egg at an average rate of 4.0% in the third and fourth weeks post infection, while egg transmission of K6222B and ts-11 vaccine was not detected. M. gallisepticum was isolated from the air sacs, ovaries and oviducts of hens infected with K6216D and K6222B, but not from those infected with ts-11 vaccine. K6216D and K6222B both induced respiratory signs, and significantly more tracheal colonization and more severe tracheal and air sac lesions than ts-11 vaccine (P ≤ 0.05). There were no substantial differences in the egg production of ts-11, K6216D and K6222B infected groups. These results provide the first conclusive evidence of transovarian transmission of an isolate genotyped as ts-11, and indicate that isolates genotyed as ts-11 vary in their virulence and ability to transmit via the egg.
    Avian Pathology 04/2015; DOI:10.1080/03079457.2015.1044890
  • [Show abstract] [Hide abstract]
    ABSTRACT: An outbreak of neurological disease was investigated in red-legged partridges between 8 and 28 days of age. Clinical signs included torticollis, head tilt and incoordination and over an initial 8 day period approximately 30-40 fatalities occurred per day. No significant gross post mortem findings were detected. Histopathological examination of the brain and bacterial cultures followed by partial sequencing confirmed a diagnosis of encephalitis due to Listeria monocytogenes. Further isolates were obtained from follow-up carcasses, environmental samples and pooled tissue samples of newly imported day-old chicks prior to placement on farm. These isolates had the same antibiotic resistance pattern as the isolate of the initial post mortem submission and belonged to the same fluorescent amplified fragment length polymorphism (fAFLP) subtype. This suggested that the isolates were very closely related or identical and that the pathogen had entered the farm with the imported day-old chicks, resulting in disease manifestation in partridges between 8 and 28 days of age. Reports of outbreaks of encephalitic listeriosis in avian species are rare and this is to the best of our knowledge the first reported outbreak in red-legged partridges.
    Avian Pathology 04/2015; DOI:10.1080/03079457.2015.1042427
  • [Show abstract] [Hide abstract]
    ABSTRACT: A surveillance method able to differentiate between vaccinated and infected animals (DIVA) is required for those countries that practice vaccination against highly pathogenic avian influenza (HPAI) H5N1. The M2e protein of influenza virus is a potentially useful DIVA antigen but little is known about the M2e antibody response and factors influencing its detection. In this study, the M2e antibody response was characterised in layer birds vaccinated and challenged with an Indonesian H5N1 virus isolate, using a single M2e peptide (sp-M2e) or four-branched-multiple-antigenic form of M2e (MAP-M2e) as antigens in two separate ELISAs. Anti-M2e antibodies were absent in chicks with high level of maternal haemagglutination inhibition (HI) antibodies and also in all layers vaccinated once, twice or three times with an inactivated commercial H5N1 vaccine. In contrast, anti-M2e antibodies were detected in vaccinated layers challenged with H5N1 virus and their presence was associated with virus isolation and an increase in HI titres. The number of birds that developed M2e antibodies, as well as the strength and duration of the M2e antibody response were strongly influenced by the length of the interval between vaccination and challenge. Birds challenged at six weeks after vaccination all developed M2e antibodies by 14 days that lasted until at least 56 days after infection. In birds challenged at two weeks after vaccination only a proportion of birds developed M2e antibodies by 14 days that lasted only until 28 days post infection. Both sp-M2e and MAP-M2e ELISAs had high diagnostic specificity but the diagnostic sensitivity of MAP-M2e ELISA was significantly higher and more effective in detecting M2e antibody in immune and infected birds. The results show that MAP-M2e ELISA would be useful for surveillance in countries using vaccination to control HPAI H5N1.
    Avian Pathology 04/2015; DOI:10.1080/03079457.2015.1042428